These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24687086)

  • 1. Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.
    Newman RG; Dee MJ; Malek TR; Podack ER; Levy RB
    Blood; 2014 May; 123(19):3045-55. PubMed ID: 24687086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production.
    Ertelt JM; Johanns TM; Rowe JH; Way SS
    Immunology; 2010 Oct; 131(2):183-91. PubMed ID: 20465570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
    Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
    Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
    J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen.
    Rapp UK; Kaufmann SH
    Int Immunol; 2004 Apr; 16(4):597-605. PubMed ID: 15039390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
    Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory phenotype CD8(+) T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes.
    Yajima T; Nishimura H; Ishimitsu R; Yamamura K; Watase T; Busch DH; Pamer EG; Kuwano H; Yoshikai Y
    Eur J Immunol; 2001 Mar; 31(3):757-66. PubMed ID: 11241280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes.
    Berg RE; Crossley E; Murray S; Forman J
    J Immunol; 2005 Aug; 175(3):1751-7. PubMed ID: 16034116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C-theta critically regulates the proliferation and survival of pathogen-specific T cells in murine listeriosis.
    Sakowicz-Burkiewicz M; Nishanth G; Helmuth U; Drögemüller K; Busch DH; Utermöhlen O; Naumann M; Deckert M; Schlüter D
    J Immunol; 2008 Apr; 180(8):5601-12. PubMed ID: 18390745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
    Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes.
    Rolph MS; Kaufmann SH
    J Immunol; 2001 Apr; 166(8):5115-21. PubMed ID: 11290793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge.
    Rowe JH; Johanns TM; Ertelt JM; Lai JC; Way SS
    Immunology; 2009 Sep; 128(1 Suppl):e471-8. PubMed ID: 19191906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.
    Bahjat KS; Prell RA; Allen HE; Liu W; Lemmens EE; Leong ML; Portnoy DA; Dubensky TW; Brockstedt DG; Giedlin MA
    J Immunol; 2007 Dec; 179(11):7376-84. PubMed ID: 18025181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of CD4+ T cells during immunization with nonviable Listeria monocytogenes causes enhanced CD8+ T cell-mediated protection against listeriosis.
    Kursar M; Köhler A; Kaufmann SH; Mittrücker HW
    J Immunol; 2004 Mar; 172(5):3167-72. PubMed ID: 14978123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of Listeria monocytogenes.
    Emoto Y; Yoshizawa I; Hurwitz R; Brinkmann V; Kaufmann SH; Emoto M
    Microbes Infect; 2008 Mar; 10(3):224-32. PubMed ID: 18321748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.
    Qian J; Hong S; Wang S; Zhang L; Sun L; Wang M; Yang J; Kwak LW; Hou J; Yi Q
    Blood; 2009 Oct; 114(18):3880-9. PubMed ID: 19654406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis.
    Hess J; Gentschev I; Miko D; Welzel M; Ladel C; Goebel W; Kaufmann SH
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1458-63. PubMed ID: 8643654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma.
    Gatza E; Okada CY
    Cancer Immunol Immunother; 2006 Apr; 55(4):420-32. PubMed ID: 16025264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.